These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5331310)

  • 1. [Research on the pathogenesis of diabetic nephropathy. Experimental histochemical, optical microscopic and biochemical studies in animals treated with protamine sulfate].
    Lenti G; Pellegrini A; Sirigu F; Pagano G; Riva A
    Minerva Med; 1966 Aug; 57(69):2789-95. PubMed ID: 5331310
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the pathogenesis of diabetic nephropathy. Electron microscopic findings in the kidneys of animals treated with protamine].
    Lenti G; Pellegrini A; Sirigu F; Pagano G
    Minerva Med; 1966 Aug; 57(69):2785-9. PubMed ID: 5918094
    [No Abstract]   [Full Text] [Related]  

  • 3. [Research on the pathogenesis of diabetic nephropathies. Further studies on nephropathy induced in animals by protamine sulfate].
    Lenti G; Pellegrini A; Sirigu F; Pagano G; Mascia V; Cirillo R
    Minerva Med; 1967 May; 58(40):1872-6. PubMed ID: 6026392
    [No Abstract]   [Full Text] [Related]  

  • 4. [FINDINGS ON DIABETIC NEPHROPATHY. I. EXPERIMENTAL REPRODUCTION IN A DIABETIC-LIKE PICTURE IN KIDNEYS OF RABBITS TREATED WITH PROTAMINE].
    LENTI G; PELLEGRINI A; SIRIGU F
    Rass Med Sarda; 1965; 68():167-81. PubMed ID: 14339847
    [No Abstract]   [Full Text] [Related]  

  • 5. Down-regulation of nitric oxide synthase in the diabetic rabbit kidney: potential relevance to the early pathogenesis of diabetic nephropathy.
    Mumtaz FH; Dashwood MR; Khan MA; Thompson CS; Mikhailidis DP; Morgan RJ
    Curr Med Res Opin; 2004 Jan; 20(1):1-6. PubMed ID: 14741064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
    Doi T; Mima A; Matsubara T; Tominaga T; Arai H; Abe H
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S21-4. PubMed ID: 18842318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male sex hormone and nephropathy in Cohen diabetic rat. (Genetically selected sucrose fed).
    Cohen AM; Rosenmann E
    Diabete Metab; 1984 Sep; 10(3):199-205. PubMed ID: 6489577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renal hemodynamic basis of diabetic nephropathy.
    O'Bryan GT; Hostetter TH
    Semin Nephrol; 1997 Mar; 17(2):93-100. PubMed ID: 9148381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rodent models of streptozotocin-induced diabetic nephropathy.
    Tesch GH; Allen TJ
    Nephrology (Carlton); 2007 Jun; 12(3):261-6. PubMed ID: 17498121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cicaprost on the progression of diabetic nephropathy in uninephrectomized streptozotocin-induced diabetic rats.
    Robles RG; Villa E; Rábano A; Alvarez E; Martínez J; Ruilope LM; Sancho JM
    J Hypertens Suppl; 1993 Dec; 11(5):S208-9. PubMed ID: 8158348
    [No Abstract]   [Full Text] [Related]  

  • 11. The pathogenesis of diabetic nephropathy.
    Dronavalli S; Duka I; Bakris GL
    Nat Clin Pract Endocrinol Metab; 2008 Aug; 4(8):444-52. PubMed ID: 18607402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of paf-acether in protamine-induced thrombocytopenia in rabbits.
    Nathan N; Aissa J; Benveniste J; Arnoux B
    Eur J Anaesthesiol; 1992 Jul; 9(4):347-52. PubMed ID: 1628640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of diabetic nephropathy.
    Mauer SM; Steffes MW; Brown DM
    Adv Nephrol Necker Hosp; 1979; 8():23-42. PubMed ID: 115242
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contemporary view on pathophysiology and pathogenesis of diabetic nephropathy. II. Pathogenesis of diabetic nephropathy].
    Grzeszczak W; Zukowska-Szczechowska E
    Pol Arch Med Wewn; 1996 May; 95(5):479-85. PubMed ID: 8848417
    [No Abstract]   [Full Text] [Related]  

  • 15. Protamine: a cardiotoxic agent with negative inotropism.
    Lee T; Lin Y
    Anesthesiology; 1991 Mar; 74(3):635. PubMed ID: 2001050
    [No Abstract]   [Full Text] [Related]  

  • 16. Osmotic polyuria: an overlooked mechanism in diabetic nephropathy.
    Wang S; Mitu GM; Hirschberg R
    Nephrol Dial Transplant; 2008 Jul; 23(7):2167-72. PubMed ID: 18456680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of the diabetic nephropathy without hyperglycemia].
    Urakawa S; Watanabe J; Inoue K; Hiramatsu S; Yamauti T; Haji M; Umeda F; Nawata H
    Fukuoka Igaku Zasshi; 1992 Feb; 83(2):107-11. PubMed ID: 1592332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin and diabetic nephropathy: a new pathogenetic factor?
    Meli S; Bruno CM
    Panminerva Med; 2001 Mar; 43(1):45-8. PubMed ID: 11319518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of diabetic nephropathy in animals and man.
    Mauer SM; Steffes MW; Michael AF; Brown DM
    Diabetes; 1976; 25(2 SUPPL):850-7. PubMed ID: 823065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
    Hamada Y; Fukagawa M
    Kobe J Med Sci; 2007; 53(1-2):53-61. PubMed ID: 17582205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.